DH
David Hoang Deutsche Bank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
8.3%
Negative
25%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $90 |
63%
upside
| 1 | -13% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Buy
Initiated
| $103 |
20%
upside
| 1 | -5.4% |
0
%
| 10 Dec ‘25 4 months ago |
|
|
|
Buy
Maintained
| $45 |
35%
upside
| 2 | -8.9% |
0
%
| 13 Nov ‘25 5 months ago |
|
|
|
Buy
Maintained
| $280 |
19%
downside
| 1 | +87% |
0
%
| 17 Oct ‘25 6 months ago |
|
|
|
Buy
Initiated
| $43 |
38%
downside
| 1 | +180% |
0
%
| 26 Sep ‘25 7 months ago |
|
|
|
Buy
Maintained
| $36 |
17%
upside
| 2 | -8.6% |
0
%
| 25 Sep ‘25 7 months ago |
|
|
|
Sell
Maintained
| $12 |
41%
downside
| 5 | -10% |
0
%
| 15 Aug ‘25 8 months ago |
|
|
|
Buy
Upgraded
| $35 |
59%
upside
| 1 | -1.3% |
0
%
| 21 May ‘25 11 months ago |
|